Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

Publications

17 Nov 2025

Open Science in a Closed World

News

17 Nov 2025

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations

Statements

13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

Press releases

10 Nov 2025

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

In the media

4 Nov 2025

Dengue : l’Europe investit 20 millions d’euros pour développer de nouveaux traitements

AFP

Press releases

4 Nov 2025

European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

Press Releases Translations

4 Nov 2025

La Commission européenne investit 20 millions d’euros pour développer des médicaments contre la dengue en partenariat avec l’Agence française de développement et DNDi

Publications

29 Oct 2025

Chagas Platform Newsletter N°15

Stories

24 Oct 2025

Jessica Robbins: A long and difficult journey with cutaneous leishmaniasis

Videos

24 Oct 2025

Road to Elimination of Kala-azar in South Asia

Videos

22 Oct 2025

The Boy Who Beat the Sandfly

In the media

21 Oct 2025

Vita dhidi ya ugonjwa wa Kala-azar vyazaa matunda Pokot baada ya mgonjwa kutibiwa na kupona

TV47 Kenya

News

14 Oct 2025

Twenty years of the Regional Kala-azar Elimination Initiative in South Asia

Viewpoints

9 Oct 2025

Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people

STAT

News

3 Oct 2025

DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness

Viewpoints

30 Sep 2025

Le développement de médicaments pour les maladies négligées doit tenir compte des enfants

Nature Africa

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Open Science in a Closed World

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

Dengue : l’Europe investit 20 millions d’euros pour développer de nouveaux traitements

European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

La Commission européenne investit 20 millions d’euros pour développer des médicaments contre la dengue en partenariat avec l’Agence française de développement et DNDi

Chagas Platform Newsletter N°15

Jessica Robbins: A long and difficult journey with cutaneous leishmaniasis

Road to Elimination of Kala-azar in South Asia

The Boy Who Beat the Sandfly

Vita dhidi ya ugonjwa wa Kala-azar vyazaa matunda Pokot baada ya mgonjwa kutibiwa na kupona

Twenty years of the Regional Kala-azar Elimination Initiative in South Asia

Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people

DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness

Le développement de médicaments pour les maladies négligées doit tenir compte des enfants

Learn more

Get in touch

Support us

Work with us